Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Page 1
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry.
Caforio ALP, Kaski JP, Gimeno JR, Elliott PM, Laroche C, Tavazzi L, Tendera M, Fu M, Sala S, Seferovic PM, Heliö T, Calò L, Blagova O, Amin A, Kindermann I, Sinagra G, Frustaci A, Bonnet D, Charron P, Maggioni AP; CMY Registry Investigators. Caforio ALP, et al. Among authors: calo l. Eur Heart J. 2024 Apr 10:ehae169. doi: 10.1093/eurheartj/ehae169. Online ahead of print. Eur Heart J. 2024. PMID: 38594778
Study aims were to describe baseline features, 1-year follow-up, and baseline predictors of outcome in clinically suspected or biopsy-proven myocarditis (2013 European Society of Cardiology criteria) in adult and paediatric patients from the EURObservational Research Programme Ca …
Study aims were to describe baseline features, 1-year follow-up, and baseline predictors of outcome in clinically suspected or biopsy-proven …
Impact of ventricular tachycardia ablation in subcutaneous implantable cardioverter defibrillator carriers: a multicentre, international analysis from the iSUSI project.
Schiavone M, Gasperetti A, Compagnucci P, Vogler J, Laredo M, Montemerlo E, Gulletta S, Breitenstein A, Ziacchi M, Martinek M, Casella M, Palmisano P, Kaiser L, Lavalle C, Calò L, Seidl S, Saguner AM, Rovaris G, Kuschyk J, Biffi M, Di Biase L, Dello Russo A, Tondo C, Della Bella P, Tilz R, Forleo GB; iSUSI investigators. Schiavone M, et al. Among authors: calo l. Europace. 2024 Mar 30;26(4):euae066. doi: 10.1093/europace/euae066. Europace. 2024. PMID: 38584394 Free PMC article. Clinical Trial.
The aim of our analysis was to test whether VT ablation (VTA) impacts long-term clinical outcomes even in subcutaneous ICD (S-ICD) carriers. ...CONCLUSION: In a real-world registry of S-ICD carriers, the combined study endpoint of arrhythmic events and cardiovascular morta …
The aim of our analysis was to test whether VT ablation (VTA) impacts long-term clinical outcomes even in subcutaneous ICD (S-ICD) ca …
Differences in underlying cardiac substrate among S-ICD recipients and its impact on long-term device-related outcomes: Real-world insights from the iSUSI registry.
Gasperetti A, Schiavone M, Milstein J, Compagnucci P, Vogler J, Laredo M, Breitenstein A, Gulletta S, Martinek M, Casella M, Kaiser L, Santini L, Rovaris G, Curnis A, Biffi M, Kuschyk J, Di Biase L, Tilz R, Tondo C, Forleo GB; i-SUSI Investigators. Gasperetti A, et al. Heart Rhythm. 2024 Apr;21(4):410-418. doi: 10.1016/j.hrthm.2023.12.007. Epub 2024 Jan 18. Heart Rhythm. 2024. PMID: 38246594
Asymptomatic Patients With Brugada ECG Pattern: Long-Term Prognosis From a Large Prospective Study.
Gaita F, Cerrato N, Giustetto C, Martino A, Bergamasco L, Millesimo M, Barbonaglia L, Carvalho P, Caponi D, Saglietto A, Bonacchi G, Bianchi F, Silvetti E, Crescenzi C, Canestrelli S, De Maio M, De Ferrari GM, Musumeci G, Rametta F, Scaglione M, Calò L. Gaita F, et al. Among authors: calo l. Circulation. 2023 Nov 14;148(20):1543-1555. doi: 10.1161/CIRCULATIONAHA.123.064689. Epub 2023 Oct 13. Circulation. 2023. PMID: 37830188 Free PMC article.
BACKGROUND: Brugada syndrome poses significant challenges in terms of risk stratification and management, particularly for asymptomatic patients who comprise the majority of individuals exhibiting Brugada ECG pattern (BrECG). The aim of this study was to evaluate the long-term …
BACKGROUND: Brugada syndrome poses significant challenges in terms of risk stratification and management, particularly for asymptomatic pati …
Cardiac resynchronization therapy non-responder to responder conversion rate in the MORE-CRT MPP trial.
Leclercq C, Burri H, Delnoy PP, Rinaldi CA, Sperzel J, Calò L, Concha JF, Fusco A, Al Samadi F, Lee K, Thibault B. Leclercq C, et al. Among authors: calo l. Europace. 2023 Oct 5;25(10):euad294. doi: 10.1093/europace/euad294. Europace. 2023. PMID: 37776313 Free PMC article. Clinical Trial.
This finding suggests that CRT benefit may be delayed or slowly incremental in a relevant proportion of patients and that the percentage of CRT responders may be higher than what has been described in short-/middle-term studies. MultiPoint Pacing does not improve CRT respo …
This finding suggests that CRT benefit may be delayed or slowly incremental in a relevant proportion of patients and that the percentage of …
Cardiac magnetic resonance-guided cardiac ablation: a case series of an early experience.
De Zan G, Calò L, Borrelli A, Guglielmo M, De Ruvo E, Rier S, van Driel V, Ramanna H, Patti G, Rebecchi M, Fusco A, Stefanini M, Simonetti G, van der Bilt I. De Zan G, et al. Among authors: calo l. Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C265-C270. doi: 10.1093/eurheartjsupp/suad051. eCollection 2023 May. Eur Heart J Suppl. 2023. PMID: 37125279 Free PMC article.
Radiofrequency (RF) catheter ablation has become a widely used therapeutic approach. However, long-term results in terms of arrhythmia recurrence are still suboptimal. ...
Radiofrequency (RF) catheter ablation has become a widely used therapeutic approach. However, long-term results in terms of arrhythmi …
New insertable cardiac monitors show high diagnostic yield and good safety profile in real-world clinical practice: results from the international prospective observational SMART Registry.
Quartieri F, Harish M, Calò L, Ebrahim I, Fusco A, Mester S, Cauti F, Park SJ, Francia P, Giovagnoni M, Adragao P, Vezi B, Lin W, Hutson CS, Grammatico A. Quartieri F, et al. Among authors: calo l. Europace. 2023 May 19;25(5):euad068. doi: 10.1093/europace/euad068. Europace. 2023. PMID: 36935638 Free PMC article.
AIMS: Insertable cardiac monitors (ICMs) are indicated for long-term monitoring of unexplained syncope or palpitations, and for detection of bradycardia, ventricular tachycardia, and/or atrial fibrillation (AF). ...
AIMS: Insertable cardiac monitors (ICMs) are indicated for long-term monitoring of unexplained syncope or palpitations, and for detec …
Biochemical Mechanisms beyond Glycosphingolipid Accumulation in Fabry Disease: Might They Provide Additional Therapeutic Treatments?
Bertoldi G, Caputo I, Driussi G, Stefanelli LF, Di Vico V, Carraro G, Nalesso F, Calò LA. Bertoldi G, et al. Among authors: calo la. J Clin Med. 2023 Mar 6;12(5):2063. doi: 10.3390/jcm12052063. J Clin Med. 2023. PMID: 36902850 Free PMC article. Review.
Currently, enzyme replacement therapy is the cornerstone of the treatment of all Fabry patients, although in the long-term it fails to completely halt the disease's progression. This suggests on one hand that the adverse outcomes cannot be justified only by the lysosomal a …
Currently, enzyme replacement therapy is the cornerstone of the treatment of all Fabry patients, although in the long-term it fails t …
89 results